XML 57 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
SHARE-BASED AND OTHER COMPENSATION PROGRAMS (Tables)
 12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of compensation costs
Compensation costs for 2017, 2016 and 2015 for share-based payment arrangements as further described herein are as follows:
 
2017
 
2016
 
2015
 
(in millions)
Performance Shares
$
18

 
$
17

 
$
18

Stock Options (Other than AB stock options)
1

 
1

 
1

AXA Shareplan
9

 
14

 
16

Restricted Awards
185

 
154

 
174

Other Compensation plans(1)
2

 
1

 
2

Total Compensation Expenses
$
215

 
$
187

 
$
211



(1)
Other compensation plans include Stock Appreciation Rights, Restricted Stock and AXA Miles.
Summary of stock option activity
A summary of the activity in the AXA and the Company's option plans during 2017 follows:

 
Options Outstanding
 
AXA Ordinary Shares
 
AXA ADRs(2)
 
AB Holding Units
 
Number
Outstanding  
(In 000’s)
 
Weighted
Average
Exercise
Price
 
Number
Outstanding
(In 000’s)
 
Weighted
Average
Exercise
Price
 
Number
Outstanding
(In 000’s)
 
Weighted
Average
Exercise
Price
Options Outstanding at January 1, 2017
9,536

 
€
21.02

 
45

 
$
24.90

 
5,085

 
$
49.45

Options granted
488

 
€
23.92

 
—

 
$
—

 
—

 
$
—

Options exercised
(1,996
)
 
€
18.02

 
(2
)
 
$
21.35

 
(1,180
)
 
$
17.04

Options forfeited, net
—

 
€
—

 
—

 
$
—

 
—

 
$
—

Options expired
(2,626
)
 
33.77

 
(8
)
 
42.62

 
(823
)
 
$
84.96

Options Outstanding at December 31, 2017
5,402

 
€
17.36

 
35

 
$
20.98

 
3,082

 
$
52.37

Aggregate Intrinsic
Value of Options Outstanding(1)
 
 
€
39,861

(2) 
 
 
$
303

 
 
 
—

Weighted Average Remaining Contractual Term (in years)
4.2

 
 
 
1.2

 
 
 
1.2

 
 
Options Exercisable at December 31, 2017
3,406

 
€
14.68

 
35

 
$
42.62

 
3,018

 
$
52.97

Aggregate Intrinsic
Value of Options Exercisable & Expected to Vest(1)
 
 
€
34,275

 
 
 
$
303

 
 
 
—

Weighted Average Remaining Contractual Term (in years)
2.8

 
 
 
1.2

 
 
 
1.1

 
 

(1)
Aggregate intrinsic value, presented in thousands, is calculated as the excess of the closing market price on December 31, 2017 of the respective underlying shares over the strike prices of the option awards.
(2)
AXA ordinary shares will be delivered to participants in lieu of AXA ADRs at exercise or maturity.
Schedule of share-based payment award, valuation assumptions
Shown below are the relevant input assumptions used to derive the fair values of options awarded in 2017, 2016 and 2015, respectively.
 
AXA Ordinary Shares
 
AB Holding Units(1)
 
2017
 
2016
 
2015
 
2017
 
2016
 
2015
Dividend yield
6.53
%
 
6.49
%
 
6.29
%
 
N/A
 
7.10
%
 
7.10
%
Expected volatility
25.05
%
 
26.60
%
 
23.68
%
 
N/A
 
31.00
%
 
32.10
%
Risk-free interest rates
0.59
%
 
0.33
%
 
0.92
%
 
N/A
 
1.30
%
 
1.50
%
Expected life in years
8.83

 
8.1

 
8.2

 
N/A
 
6.0

 
6.0

Weighted average fair value per option at grant date
$
2.01

 
$
2.06

 
$
1.73

 
N/A
 
$
2.75

 
$
4.13



(1)
There were no options to buy AB Holding Units awarded during 2017. As such, the input assumptions for 2017 are not applicable.
Schedule of share-based compensation, restricted stock units award activity
The following table summarizes restricted AXA ordinary share activity for 2017. In addition, approximately 11,069 RSUs were granted during 2017 with graded vesting over a weighted average service period of 2.06 years. 4
 
Shares of
Restricted      
Stock
 
Weighted
Average
Grant Date    
Fair Value
Unvested as of January 1, 2017
36,306

 
$
24.46

Granted
12,929

 
$
27.49

Vested
11,819

 
$
24.30

Unvested as of December 31, 2017
37,416

 
$
24.04